Hong Kong Consumer Durables Stock News

The China Tangshang Holdings Limited ( HKG:674 ) share price has done very well over the last month, posting an...

China Taiping Insurance Holdings Company Limited ( HKG:966 ) shares have had a really impressive month, gaining 29...

Wah Sun Handbags International Holdings Limited ( HKG:2683 ) shareholders have had their patience rewarded with a 32...

Despite an already strong run, Sun.King Technology Group Limited ( HKG:580 ) shares have been powering on, with a gain...

Shanghai MicroPort MedBot (Group) recently announced the resignation of three senior board members, including the chairperson, and proposed amendments to its board structure and governance documents, pending approval at an extraordinary general meeting. These governance changes mark a significant moment for the company, as leadership transitions and board expansion could reshape decision-making processes and future growth initiatives. We'll explore how these multiple high-level resignations...

On November 5, 2025, Ceres Power Holdings plc announced it has signed a manufacturing licence agreement with Weichai Power for the production of its solid oxide fuel cell technology, enabling Weichai to produce cells and stacks for stationary power systems in China targeting AI data centres, commercial buildings, and industrial sectors. This agreement not only expands Ceres' roster of manufacturing partners to four but also marks a shift for Weichai Power into advanced energy solutions that...

At EICMA 2025, Yadea Group Holdings unveiled its latest high-performance electric motorcycles and an integrated charging ecosystem, debuting innovations such as the Velax series with ultra-fast charging, next-generation sodium-ion batteries, and a range of intelligent mobility solutions. A key highlight is Yadea’s focus on making rapid charging and sodium battery technology widely accessible, underlining its ambitions to accelerate sustainable electric mobility on a global scale. As Yadea...

CNOOC (SEHK:883) just released its earnings report for the first nine months of 2025, highlighting a decline in both revenue and net income compared to the previous year. This development is catching investors’ attention. See our latest analysis for CNOOC. CNOOC's shares have had an impressive run, with a 20.7% share price return over the past month and a strong 44.4% total shareholder return for the past year, despite the recent earnings disappointment. Momentum remains solid, suggesting...

Recent shifts in Guinea's mining sector, including new local processing mandates and transferred concessions, could impact global aluminum supply chains. For Aluminum Corporation of China (SEHK:2600), these changes may affect input costs and future supply stability. See our latest analysis for Aluminum Corporation of China. Aluminum Corporation of China’s momentum has been nothing short of remarkable. After a steady climb throughout the year, the share price has spiked by 161.85%...

Ascentage Pharma Group International (SEHK:6855) saw attention rise after announcing that new clinical and preclinical results on olverembatinib, lisaftoclax, and APG-5918 will be featured at the 67th ASH Annual Meeting. This recognition for its drug candidates highlights the company’s development programs and keeps them in focus for investors. See our latest analysis for Ascentage Pharma Group International. This spotlight at ASH comes after a year of strong momentum for Ascentage Pharma...

Industrial and Commercial Bank of China (SEHK:1398) just completed a major capital raising, issuing RMB40 billion in undated Additional Tier 1 Capital Bonds. This move increases the bank’s financial cushion for future expansion. See our latest analysis for Industrial and Commercial Bank of China. ICBC’s recent surge stands out, with its share price jumping 16.25% over the past month and 35.67% year-to-date, reflecting renewed optimism as capital strength and dividend announcements boost...

CK Hutchison Holdings (SEHK:1) has published a quarterly trading update for its telecom subsidiary, featuring unaudited financial results for the quarter ended September 30, 2025. The company urged investors to treat this data with caution. See our latest analysis for CK Hutchison Holdings. Following the telecom update, CK Hutchison Holdings’ shares have surged, with a 34.6% share price return year to date and a 44.9% total shareholder return over the past year. With momentum building on...

SJM Holdings recently reported its third quarter 2025 results, revealing a 15% decline in adjusted EBITDA and a 91.1% decrease in net profit year-on-year, with both total net revenue and net gaming revenue also dropping compared to the prior year. This sharp drop in profitability highlights a challenging period for the company's core gaming operations in Macau, pointing to underlying headwinds in the operating environment. We'll explore how the significant year-on-year decline in...

In early November 2025, Akeso announced a series of pipeline milestones, including the first patient dosing in a Phase I trial of its mRNA vaccine AK154, the presentation of promising Overall Survival results for ivonescimab in EGFR-mutated non-small cell lung cancer at SITC, and new preclinical data for its novel antibody AK135. The rapid progress across both late-stage and innovative early-stage assets underscores Akeso's efforts to expand its oncology portfolio while solidifying its...

Semiconductor Manufacturing International (SEHK:981) shares have seen some movement in recent sessions, with investors considering the company's recent performance. Over the past month, the stock dipped 9%, although it remains up sharply in the past 3 months. See our latest analysis for Semiconductor Manufacturing International. After a phenomenal surge earlier this year, Semiconductor Manufacturing International’s 1-year total shareholder return now sits at nearly 170%. While momentum has...

COSCO SHIPPING Ports Limited recently reported its third quarter and nine-month results for the period ended September 30, 2025, with sales rising to US$428.67 million and net income at US$82.5 million in the third quarter, both higher than the same period last year. A unique detail from the announcement is that while sales and net income grew, basic and diluted earnings per share for the third quarter declined slightly compared to a year ago, reflecting the impact of share issuance on...

On November 5, 2025, The Hongkong and Shanghai Hotels, Limited reported its unaudited third quarter operating results, revealing varied RevPAR figures across key regions, including HK$2,477 for Greater China and HK$9,234 for Europe. While Greater China and Other Asia saw year-over-year declines in RevPAR, Europe and the USA experienced solid gains, indicating shifting regional demand patterns for The Peninsula Hotels. We'll explore how diverging RevPAR trends, particularly the strong growth...

Crédit Agricole has extended its lease for about 85,000 square feet at Swire Properties (SEHK:1972) Pacific Place until 2034. This move reaffirms a partnership that highlights ongoing faith in Hong Kong's office property sector. See our latest analysis for Swire Properties. The renewed partnership with Crédit Agricole arrives as Swire Properties’ share price shows robust momentum, jumping 4.1% in a single day and building on a year-to-date share price return of nearly 47%. The stock’s...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...

Unfortunately for some shareholders, the Guotai Junan International Holdings Limited ( HKG:1788 ) share price has dived...

China Life Insurance Company Limited ( HKG:2628 ) shares have had a really impressive month, gaining 28% after a shaky...

To the annoyance of some shareholders, Cinese International Group Holdings Limited ( HKG:1620 ) shares are down a...

People's Insurance Company (Group) of China recently reported earnings results for the nine months ended September 30, 2025, with net income rising to CNY 46.82 billion from CNY 36.33 billion the prior year and basic earnings per share increasing from CNY 0.82 to CNY 1.06; shareholders also approved an interim dividend of RMB 0.75 per 10 Shares to be paid in December 2025. This combination of improved profitability and a higher interim dividend highlights management's confidence in the...

Innovent Biologics (SEHK:1801) is in focus after presenting early results from its first-in-human Phase 1 trial of IBI3016, a new RNA interference treatment for hypertension, at the American Heart Association scientific sessions. See our latest analysis for Innovent Biologics. Strong early data from Innovent’s novel RNAi hypertension treatment has certainly kept the spotlight on the stock, especially after a string of robust product launches and revenue growth. While the share price return...